Psychological interventions for individuals with long COVID: a systematic review and meta-analysis.

Health Psychol RevMar 25, 2026 (epub)
Clinical ResearchPsychiatry

Cristina Garriga-Salvó, Emiliano Navarro, Cristina Lidón-Moyano et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis assessed psychological interventions for people with long COVID, focusing on symptoms and quality of life. Nineteen studies were included in the review and 14 in the meta-analysis, using random-effects synthesis. Interventions were associated with significant reductions in anxiety (SMD = -0.64; 95% CI: -1.18 to -0.10), depression (SMD = -0.41; 95% CI: -0.73 to -0.10) and fatigue (SMD = -1.37; 95% CI: -2.48 to -0.26). Significant improvement in quality of life was reported only for self-perceived health-related quality of life.

Key findings

  • Anxiety symptoms decreased significantly with psychological interventions (SMD = -0.64; 95% CI: -1.18 to -0.10).
  • Depression symptoms decreased significantly (SMD = -0.41; 95% CI: -0.73 to -0.10).
  • Fatigue decreased significantly (SMD = -1.37; 95% CI: -2.48 to -0.26).
  • Significant quality-of-life improvement was limited to self-perceived health-related quality of life (SMD = 7.59; 95% CI: 3.70-11.48).

Why it matters

Long COVID can affect multiple aspects of functioning, and persistent fatigue and psychological symptoms may contribute to substantial patient burden. The pooled findings suggest psychological interventions may help address anxiety, depression and fatigue, while evidence of quality-of-life benefit was narrower. These results support considering psychological care as one component of multidisciplinary recovery, while recognising that the review does not establish effects for every intervention or outcome.

What to keep in mind

The review included 19 studies, with only 14 contributing to meta-analysis; the abstract does not report further details on study quality or heterogeneity.

Source

Published in Health Psychol Rev. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.